Current global status of male reproductive healthReview Published on 2024-04-122024-09-05 Journal: Human Reproduction Open [Category] update2024, [키워드] Andrology Contraception economics education epigenetics Fertility genetics male infertility male reproductive health Policy [DOI] 10.1093/hropen/hoae017 PMC 바로가기 [Article Type] Review
Adolescent Perspectives on the Use of Telemedicine for Confidential Health Care: An Exploratory Mixed-Methods StudyArticle Published on 2023-05-112024-09-05 Journal: The Journal of adolescent health : official public [Category] update2024, [키워드] Access to care Adolescent health services adolescents confidentiality Contraception Sexual and gender minorities Sexual Health Telemedicine [DOI] 10.1016/j.jadohealth.2023.04.005 PMC 바로가기 [Article Type] Article
Infection with SARS-CoV-2 is associated with menstrual irregularities among women of reproductive ageArticle Published on 2022-10-262022-11-15 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] 95% CI Adjusting age antibodies antibody approved Biological Chi-square collected data Contraception COVID-19 pandemic COVID-19 vaccination Depression described detectable enrolled Enrollment EUA examined Factor Fisher Health Logistic regression loneliness mechanism menstrual menstrual irregularity mitigate pandemic provided Psychological Rapid test recruited reproductive responsible SARS-CoV-2 SARS-CoV-2 IgG antibodies SARS-CoV-2 IgG antibody SARS-COV-2 infection Stress undetectable vaccination variables Whole blood women [DOI] 10.1371/journal.pone.0276131 PMC 바로가기
New Perspectives on Antimicrobial Agents: Molnupiravir and Nirmatrelvir/Ritonavir for Treatment of COVID-19항균제에 대한 새로운 관점: 코로나19 치료를 위한 몰누피라비르 및 니르마트렐비르/리토나비르Article Published on 2022-08-162022-09-11 Journal: Antimicrobial Agents and Chemotherapy [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus addition adjusted relative risk antimicrobial Antiviral cause childbearing potential children Complication Contraception coronavirus disease Coronavirus-2 COVID-19 cytochrome P450 Cytochrome P450 enzymes death drug Drug administration Drug-to-drug interaction Each Emergency use authorization food hospitalizations in vitro inhibit limit management medication metabolism Mild mild to moderate moderate molnupiravir morbidity and mortality Mutation New Nirmatrelvir Nirmatrelvir/ritonavir nonspecific outcome pandemic Patient polymerase polyprotein pregnant protease proteolytic cleavage reduction Relative risk Replication Respiratory disease risk Ritonavir SARS-CoV-2 Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 significantly target tested Toxicity Treatment treatment regimen U.S. Food and Drug Administration variant viral replication virus virus production [DOI] 10.1128/aac.02404-21 PMC 바로가기 [Article Type] Article
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trialClinical Trial Published on 2022-08-102022-10-06 Journal: The Lancet. Infectious Diseases [Category] SARS, 변종, 진단, [키워드] 1:1 Administered administration adverse event adverse events age amplifying analysed Analysis antibody concentration Antigen assigned available data BMI booster booster dose Breastfeeding Coalition Contraception COVID-19 pandemic diagnosis of COVID-19 dose Efficacy enrolled evaluated event Evidence exclusion geometric mean titre GMT group healthy homologous IgG immune response inactive increase in initial intramuscular Local Matrix-M median Medical conditions Novavax NVX-CoV2373 outcome participant per-protocol per-protocol population phase 2 trial phase 3 study Placebo placebo-controlled pregnant primary endpoint proportion Protein randomisation randomised Randomly reaction reactogenicity receive Recombinant spike protein recruited regimens Registered Safety SARS-CoV SARS-CoV-2 SARS-CoV-2 strain SARS-CoV-2 vaccine SARS-CoV-2 variant screened serum IgG single booster dose stratified Support the SARS-CoV-2 the vaccine titres Treatment Trial USA vaccination Vaccine variant were excluded women [DOI] 10.1016/S1473-3099(22)00420-0 PMC 바로가기 [Article Type] Clinical Trial
Exclusion of Reproductive-Aged Women in COVID-19 Vaccination and Clinical TrialsResearch article Published on 2022-06-012022-10-05 Journal: Women's Health Issues [Category] COVID19(2023년), SARS, 신약개발, 임상, [키워드] Analysis analyzed association Breastfeeding childbearing potential clinical Clinical treatment clinical trial clinical trials Contraception coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccine database excluded exclusion exclusion criteria global pandemic individual individuals lactating lactation library male Medicine participant Pregnancy pregnant profiles required Result Sponsor study participation Treatment treatment trials trials Vaccine [DOI] 10.1016/j.whi.2022.06.004 [Article Type] Research article
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study건강한 성인에서 AS03 보조제 SARS-CoV-2 재조합 단백질 백신(CoV2 preS dTM)의 안전성 및 면역원성: 2상, 무작위, 용량 찾기, 다기관 연구의 중간 결과Clinical Trial Published on 2022-05-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단, [키워드] 95% CI abstinence adjuvants Adults adverse event adverse events Adverse reaction Adverse reactions age All participant All participants antibody Antibody titre Antigen AS03 assessments assigned authority baseline booster vaccination candidate vaccine Chemotherapy childbearing potential clinical development Clinical research clinical trial Cohort Contraception COVID-19 vaccine D614G variant development dose effective Endpoint enrolled evaluated expected fixed Frequency geometric mean geometric mean titre GMT GMT ratio GMTs groups healthy High dose High-dose high-dose group Immunocompromised immunogenicity increase in increased risk injection injection site Injections intensity interim results investigator investigators involved Laboratory lactating low dose low-dose medical condition Medical conditions medium medium dose Mild mild to moderate moderate multicentre Neutralising Antibodies neutralising antibody neutralising antibody titre neutralising antibody titres occurred Older Older adults Organ transplant outcome outcome assessor outcome assessors parallel-group participant Participants Phase 2 Phase 3 positive prefusion pregnant primary immunogenicity progression proportion Protein protocol provided pseudovirus neutralisation assay randomised Randomly reactogenicity receive Registered reported Research research and development responses robust Safety safety analysis safety endpoints safety profile Sanofi Pasteur SARS-CoV-2 second dose second vaccination selected Serious Adverse Event Serious Adverse Events serodiagnostic Seven severe COVID-19 Stratification study period supported systemic test result titre titres Treatment treatment group treatment groups Trial USA vaccination Vaccine was done were excluded were measured yes or no [DOI] 10.1016/S1473-3099(21)00764-7 PMC 바로가기 [Article Type] Clinical Trial
The effects of text reminders on the use of family planning services: evidence from a randomised controlled trial in urban MozambiqueRandomized Controlled Trial Published on 2022-04-012022-10-05 Journal: BMJ Global Health [Category] 임상, [키워드] Analysis assigned Community conducted Contraception contraceptive method control arm Effect enrolled Evidence family Final Follow-up Health health worker include increase individual Individual randomized trial intention-to-treat analysis outcomes Planning Population Probability Program provided Public public health Randomised control trial. randomised controlled trial Randomized Randomly receive reported risk service statistically significant text reminder treatment group Trial unmet need women [DOI] 10.1136/bmjgh-2021-007862 PMC 바로가기 [Article Type] Randomized Controlled Trial
COVID-19 and hormonal contraceptionEditorial Published on 2022-04-012022-10-05 Journal: Case Reports in Women's Health [Category] 유전자 메커니즘, [키워드] ACE2 Coagulation Contraception COVID-19 Immunity Oestrogen [DOI] 10.1016/j.crwh.2022.e00389 [Article Type] Editorial
Factors related to delays in obtaining contraception among pregnancy-capable adults in New York state during the COVID-19 pandemic: The CAP studyArticle Published on 2022-03-012023-07-08 Journal: Sexual & reproductive healthcare : official journal of the Swedish [Category] COVID19(2023년), [키워드] access barriers birth control Contraception COVID-19 Telemedicine [DOI] 10.1016/j.srhc.2022.100697 PMC 바로가기